Our data showed that after treatment with rapamycin, the malignant behaviors of these AIM2 deficient HCC cells, including proliferation (Figure 6A–6B), colony formation (Figure 6C) and invasion capabilities (Figure 6D) were significantly suppressed. This evidence concerns the gene AIM2 and hepatocellular carcinoma.